Javier Valdivia

6.6k total citations
26 papers, 321 citations indexed

About

Javier Valdivia is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Javier Valdivia has authored 26 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Javier Valdivia's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). Javier Valdivia is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). Javier Valdivia collaborates with scholars based in Spain, United States and Switzerland. Javier Valdivia's co-authors include J. M. Suárez Grau, María José Serrano, José A. Lorente, Diego de Miguel‐Pérez, José Luis García Puche, M. Carmen Garrido-Navas, Caridad Díaz, Yolanda Escobar, Antonio Irigoyen López and Juan Antonio Marchal and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Javier Valdivia

20 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Valdivia Spain 8 152 100 91 70 55 26 321
Vidhya Karivedu United States 10 129 0.8× 71 0.7× 71 0.8× 129 1.8× 24 0.4× 35 322
Yung‐Bin Kuo Taiwan 11 112 0.7× 34 0.3× 133 1.5× 81 1.2× 90 1.6× 15 340
Thiago Bueno de Oliveira Brazil 10 143 0.9× 70 0.7× 56 0.6× 100 1.4× 76 1.4× 35 299
Chunju Zhou China 10 99 0.7× 41 0.4× 93 1.0× 80 1.1× 43 0.8× 49 326
Esmée P. Hoefsmit Netherlands 9 188 1.2× 60 0.6× 72 0.8× 97 1.4× 33 0.6× 14 355
Han Xiao United States 10 124 0.8× 106 1.1× 65 0.7× 165 2.4× 49 0.9× 34 332
Jugao Fang China 11 89 0.6× 100 1.0× 111 1.2× 53 0.8× 85 1.5× 41 312
Jacinto J. Regalado United States 8 131 0.9× 69 0.7× 141 1.5× 56 0.8× 58 1.1× 16 302
Toshiyuki Nakasone Japan 10 58 0.4× 45 0.5× 52 0.6× 47 0.7× 33 0.6× 45 244
Mary Lowery‐Nordberg United States 11 77 0.5× 29 0.3× 117 1.3× 52 0.7× 49 0.9× 19 288

Countries citing papers authored by Javier Valdivia

Since Specialization
Citations

This map shows the geographic impact of Javier Valdivia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Valdivia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Valdivia more than expected).

Fields of papers citing papers by Javier Valdivia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Valdivia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Valdivia. The network helps show where Javier Valdivia may publish in the future.

Co-authorship network of co-authors of Javier Valdivia

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Valdivia. A scholar is included among the top collaborators of Javier Valdivia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Valdivia. Javier Valdivia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ku, Gabriel De la Cruz, et al.. (2025). Outcomes and Current State of Deep Inferior Epigastric Perforator Flap Surgery in Peru and Mexico. Plastic & Reconstructive Surgery Global Open. 13(2). e6532–e6532.
2.
Martín-Liberal, Juan, Iván Márquez‐Rodas, Ainara Soria, et al.. (2025). Challenges and perspectives in the management of BRAF-mutated metastatic melanoma: Systemic treatment sequencing and brain metastases. Cancer Treatment Reviews. 133. 102886–102886. 1 indexed citations
3.
Díaz, Caridad, María Ángel García, Houría Boulaiz, et al.. (2024). Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study. British Journal of Dermatology. 190(5). 740–750. 4 indexed citations
4.
Trigo, José, Khalil Zaman, María Ángeles Sala, et al.. (2023). EP13.07-06 Efficacy of Platinum Given after Lurbinectedin in Sensitive Relapsed SCLC Patients. Journal of Thoracic Oncology. 18(11). S708–S709.
5.
6.
Berciano‐Guerrero, Miguel‐Ángel, Rocío Lavado-Valenzuela, Aurelio A. Moya‐García, et al.. (2022). Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy. Biomedicines. 10(2). 284–284. 7 indexed citations
7.
8.
Pérez-Ruiz, Elísabeth, Miguel‐Ángel Berciano‐Guerrero, Javier Valdivia, et al.. (2020). Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice. Clinical & Translational Oncology. 22(10). 1778–1785. 16 indexed citations
9.
Valdivia, Javier, et al.. (2019). Pneumocystis jirovecii pneumonia in a non-small cell lung cancer patient on chemoradiotherapy: A case report. SHILAP Revista de lepidopterología. 8(1). 53–53. 6 indexed citations
10.
Arriola, Edurne, Ramón García Gómez, Pilar Díz, et al.. (2018). Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain. BMC Cancer. 18(1). 106–106. 14 indexed citations
11.
12.
Berrocal, Alfonso, Ana Arance, José A. López-Martín, et al.. (2014). Ipilimumab for advanced melanoma. Melanoma Research. 24(6). 577–583. 32 indexed citations
13.
Arriola, Edurne, Ramón García Gómez, Pilar Díz, et al.. (2014). Observational retrospective study to describe the management of advanced epidermal growth factor receptor (EGFR) mutated (M+) non-small cell lung cancer (NSCLC) patients (pts) in Spain (NCT01795352).. Journal of Clinical Oncology. 32(15_suppl). e19133–e19133. 2 indexed citations
14.
Noguera, José, et al.. (2014). Transvaginal Approach for Nongynecologic Intraperitoneal Procedures. International Journal of Clinical Medicine. 5(21). 1417–1429.
15.
Delgado, Juan Ramón, et al.. (2010). 544 DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy in breast cancer. European Journal of Cancer Supplements. 8(7). 173–173. 1 indexed citations
16.
Muros, M.A., Mariela Varsavsky, Pablo Rozas, et al.. (2009). Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues. Clinical & Translational Oncology. 11(1). 48–53. 16 indexed citations
17.
18.
19.
Muro, Xavier García del, Pablo Maroto, A. Barnadas, et al.. (2003). 884 Long-term results following one course of adjuvant chemotherapy for high-risk stage I non-seminomatous germ cell tumors: the Spanish germ cell cancer group experience. European Journal of Cancer Supplements. 1(5). S266–S266. 1 indexed citations
20.
González‐Flores, Encarnación, et al.. (2003). 241 Phase II study of bl-weekly oxaliplatin, UFT and leucovorin (OXA-UFT-LV) in pretreated metastatic colorectal cancer(MCRC). European Journal of Cancer Supplements. 1(5). S74–S75. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vidhya Karivedu Breakdown of academic impact, for papers by Yung‐Bin Kuo Breakdown of academic impact, for papers by Thiago Bueno de Oliveira Breakdown of academic impact, for papers by Chunju Zhou Breakdown of academic impact, for papers by Esmée P. Hoefsmit Breakdown of academic impact, for papers by Han Xiao Breakdown of academic impact, for papers by Jugao Fang Breakdown of academic impact, for papers by Jacinto J. Regalado Breakdown of academic impact, for papers by Toshiyuki Nakasone Breakdown of academic impact, for papers by Mary Lowery‐Nordberg
Rankless by CCL
2026